Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Hilbert

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Blood|October 19, 2007
Multiple signaling pathways promote B lymphocyte stimulator dependent B-cell growth and survivalRobert T Woodland, Casey J Fox, Madelyn R Schmidt, et al.
Arthritis and Rheumatism|April 11, 2003
Local production of B lymphocyte stimulator protein and APRIL in arthritic joints of patients with inflammatory arthritisSoon-Min Tan, Dong Xu, Viktor Roschke, et al.
Molecular Cancer Therapeutics|June 23, 2022
Preclinical Efficacy of BCMA-Directed CAR T Cells Incorporating a Novel D Domain Antigen Recognition DomainJanine M Buonato, Justin P Edwards, Liubov Zaritskaya, et al.
Clinical Immunology (Orlando, Fla.)|August 8, 2002
B lymphocyte stimulator protein-associated increase in circulating autoantibody levels may require CD4+ T cells: lessons from HIV-infected patientsWilliam Stohl, Gurtej S Cheema, William S Briggs, et al.
Journal of Molecular Recognition : JMR|September 24, 2004
Discovery of high-affinity peptide binders to BLyS by phage displayTony J Fleming, Meena Sachdeva, Marko Delic, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 9, 2002
BLyS and APRIL form biologically active heterotrimers that are expressed in patients with systemic immune-based rheumatic diseasesViktor Roschke, Svetlana Sosnovtseva, Christopher D Ward, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 25, 2024
Controlling CAR-T cell activity and specificity with synthetic SparX adaptersJustin P Edwards, Jeffrey S Swers, Janine M Buonato, et al.
Mabs|August 7, 2012
Simultaneous targeting of TNF and Ang2 with a novel bispecific antibody enhances efficacy in an in vivo model of arthritisPalanisamy Kanakaraj, Bridget A Puffer, Xiao-Tao Yao, et al.
Mabs|April 12, 2013
Monoclonal antibody therapeutics with up to five specificities: functional enhancement through fusion of target-specific peptidesDavid W LaFleur, Donara Abramyan, Palanisamy Kanakaraj, et al.
Arthritis and Rheumatism|November 13, 2003
Generation and characterization of LymphoStat-B, a human monoclonal antibody that antagonizes the bioactivities of B lymphocyte stimulatorKevin P Baker, Bryan M Edwards, Sarah H Main, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Blood|October 19, 2007
Multiple signaling pathways promote B lymphocyte stimulator dependent B-cell growth and survivalRobert T Woodland, Casey J Fox, Madelyn R Schmidt, et al.
Arthritis and Rheumatism|April 11, 2003
Local production of B lymphocyte stimulator protein and APRIL in arthritic joints of patients with inflammatory arthritisSoon-Min Tan, Dong Xu, Viktor Roschke, et al.
Molecular Cancer Therapeutics|June 23, 2022
Preclinical Efficacy of BCMA-Directed CAR T Cells Incorporating a Novel D Domain Antigen Recognition DomainJanine M Buonato, Justin P Edwards, Liubov Zaritskaya, et al.
Clinical Immunology (Orlando, Fla.)|August 8, 2002
B lymphocyte stimulator protein-associated increase in circulating autoantibody levels may require CD4+ T cells: lessons from HIV-infected patientsWilliam Stohl, Gurtej S Cheema, William S Briggs, et al.
Journal of Molecular Recognition : JMR|September 24, 2004
Discovery of high-affinity peptide binders to BLyS by phage displayTony J Fleming, Meena Sachdeva, Marko Delic, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 9, 2002
BLyS and APRIL form biologically active heterotrimers that are expressed in patients with systemic immune-based rheumatic diseasesViktor Roschke, Svetlana Sosnovtseva, Christopher D Ward, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 25, 2024
Controlling CAR-T cell activity and specificity with synthetic SparX adaptersJustin P Edwards, Jeffrey S Swers, Janine M Buonato, et al.
Mabs|August 7, 2012
Simultaneous targeting of TNF and Ang2 with a novel bispecific antibody enhances efficacy in an in vivo model of arthritisPalanisamy Kanakaraj, Bridget A Puffer, Xiao-Tao Yao, et al.
Mabs|April 12, 2013
Monoclonal antibody therapeutics with up to five specificities: functional enhancement through fusion of target-specific peptidesDavid W LaFleur, Donara Abramyan, Palanisamy Kanakaraj, et al.
Arthritis and Rheumatism|November 13, 2003
Generation and characterization of LymphoStat-B, a human monoclonal antibody that antagonizes the bioactivities of B lymphocyte stimulatorKevin P Baker, Bryan M Edwards, Sarah H Main, et al.
Pageof 2